P. Schaefer Price
Direttore/Membro del Consiglio presso Arbutus Biopharma, Inc.
Posizioni attive di P. Schaefer Price
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
Arbutus Biopharma, Inc.
 Arbutus Biopharma, Inc. BiotechnologyHealth Technology Arbutus Biopharma, Inc. engages in the research and development of pharmaceutical products for Hepatitis B. Its operation includes covalently closed circular DNA, Capsid Assembly, Cyclophilins, and Surface Antigen. The company was founded by Patrick T. Higgins, Michael J. Sofia, Michael J. McElhaugh, and Bryce A. Roberts in May 2012 and is headquartered in Doylestown, PA. | Direttore/Membro del Consiglio | 01/08/2014 | - |
Storia della carriera di P. Schaefer Price
Precedenti posizioni note di P. Schaefer Price
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
Pharmasset, Inc.
 Pharmasset, Inc. Pharmaceuticals: OtherHealth Technology Pharmasset, Inc. developed drugs to treat viral infections. It focued in the development of oral therapeutics for the treatment of hepatitis C virus (HCV) infection. The company was founded in 1998 and was headquartered in Princeton, NJ. | Direttore/Membro del Consiglio | 19/01/2011 | 12/01/2012 |
| Presidente | 01/06/2004 | 12/01/2012 | |
| Lakeshore Bioventures | Corporate Officer/Principal | 01/07/2001 | 01/09/2002 |
| PowderJect Vaccines, Inc. | Presidente | 01/01/1997 | 01/07/2001 |
| Burrill & Craves | Corporate Officer/Principal | - | - |
Formazione di P. Schaefer Price
| University of Wisconsin | Undergraduate Degree |
| University of Minnesota | Masters Business Admin |
Statistiche
Distribuzione geografica
| Stati Uniti | 8 |
Posizioni
| Director/Board Member | 2 |
| President | 2 |
| Corporate Officer/Principal | 2 |
Settori
| Health Technology | 3 |
| Consumer Services | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Aziende private | 5 |
|---|---|
Pharmasset, Inc.
Pharmasset, Inc. Pharmaceuticals: OtherHealth Technology Pharmasset, Inc. developed drugs to treat viral infections. It focued in the development of oral therapeutics for the treatment of hepatitis C virus (HCV) infection. The company was founded in 1998 and was headquartered in Princeton, NJ. | Health Technology |
Arbutus Biopharma, Inc.
Arbutus Biopharma, Inc. BiotechnologyHealth Technology Arbutus Biopharma, Inc. engages in the research and development of pharmaceutical products for Hepatitis B. Its operation includes covalently closed circular DNA, Capsid Assembly, Cyclophilins, and Surface Antigen. The company was founded by Patrick T. Higgins, Michael J. Sofia, Michael J. McElhaugh, and Bryce A. Roberts in May 2012 and is headquartered in Doylestown, PA. | Health Technology |
| Burrill & Craves | |
| PowderJect Vaccines, Inc. | |
| Lakeshore Bioventures |
- Borsa valori
- Insiders
- P. Schaefer Price
- Esperienza
